Radiotherapy versus radiochemotherapy with cisplatin in treatment of cervical cancer.Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor.Maternal plasma procalcitonin concentrations in pregnancy complicated by preterm premature rupture of membranesA Common Profile of Disordered Angiogenic Factor Production and the Exacerbation of Inflammation in Early Preeclampsia, Late Preeclampsia, and Intrauterine Growth RestrictionDiagnostic Potential of Evaluation of SDF-1α and sRAGE Levels in Threatened Premature Labor.Development of a focal segmental glomerulosclerosis after pregnancy complicated by preeclampsia: case report and review of literature.Ischemic placental syndrome--prediction and new disease monitoring.The Determination of Procalcitonin Concentration in Early-Onset Neonatal Infection.Soluble and Endogenous Secretory Receptors for Advanced Glycation End Products in Threatened Preterm Labor and Preterm Premature Rupture of Fetal MembranesSuccessful outcome of pregnancy complicated by Werner's syndrome.Novel View on Umbilical Cord Blood and Maternal Peripheral Blood-an Evidence for an Increase in the Number of Circulating Stem Cells on Both Sides of the Fetal-Maternal Circulation Barrier.Maternal endothelial damage as a disorder shared by early preeclampsia, late preeclampsia and intrauterine growth restriction.Using Doppler ultrasound of the uterine and umbilical arteries and disordered angiogenesis markers (sFlt-1/PlGF) in unified monitoring of ischemic placental syndrome patients.Do the physiological aging of the placenta and the changes in angiogenesis marker sFlt-1 and PlGF concentrations predispose patients to late-onset preeclampsia?Procalcitonin in cervicovaginal secretion in pregnancies complicated by preterm labor--a preliminary report.sFlt-1/PlGF and Doppler ultrasound parameters in SGA pregnancies with confirmed neonatal birth weight below 10th percentileUrinary excretion of brush-border enzymes of the proximal renal tubules in pregnant women with hypertensive disordersDoes prenatal antibiotic therapy compromise the diagnosis of early-onset infection and management of the neonate?Successful pregnancy in the patient with Fanconi-Bickel syndrome undergoing daily hemodialysisMaternal serum and vaginal fluid C-reactive protein levels do not predict early-onset neonatal infection in preterm premature rupture of membranesIsoprostanes 8-iPF2α-III: risk markers of premature rupture of fetal membranes?Value of Vaginal Fluid Proinflammatory Cytokines for the Prediction of Early-Onset Neonatal Infection in Preterm Premature Rupture of the MembranesMaternal venous procalcitonin levels do not correlate with umbilical cord blood and venous blood concentrations in the neonateAre vaginal fluid procalcitonin levels useful for the prediction of subclinial infection in patients with preterm premature rupture of membranes?Maternal plasma procalcitonin concentrations in patients with preterm labor and intact membranes - prediction of preterm delivery and admission-to-delivery intervalProinflammatory cytokines and other indications of inflammation in cervico-vaginal secretions and preterm deliveryMaternal serum proinflammatory cytokines in preterm labor with intact membranes: neonatal outcome and histological associations
P50
Q33382705-AD4D8D54-018C-481F-8672-286541FF6AF5Q35658848-802359A9-F4AF-4651-A7BF-4A375CC7E8FBQ35925367-04CEB684-6A38-4DE7-A7E1-6F32D7AAE00AQ36167912-63875C5D-628F-483E-AA40-0F7EFE717C8EQ37172011-65E73454-FB7D-4973-BFD0-E8D61761D27BQ38525535-185B640C-3751-46D7-9945-95DBF90C8C10Q38601408-24E921EC-BABC-48B5-8DAE-543F22F81E6CQ40631876-988182ED-1FB7-430A-8707-9F2A62C56230Q40977776-4CF5F706-026D-413A-8AE1-26F56D2ECE8AQ44549906-A81540A7-08E1-4F6F-8137-9F19CA386797Q47122686-8B26EC03-3F01-4F10-B166-258D271EC17EQ51316340-1272BBAB-C4E5-4E37-9B29-31F6D1CD4E30Q51737729-1EDD2120-E407-4214-A301-8FC24902A984Q51802500-EB6431E1-83AF-4EF3-A822-77D9D8E77E3BQ54184939-086B1BE9-ECDE-49C6-AF58-F68D62B460ACQ61945599-AF2CD4F8-296A-404D-8253-8454E6567186Q61945600-52A18E9D-B68B-4955-8985-96672309E507Q61945602-9C0BD125-3EF0-4FC7-AF6C-42496A2E4BCEQ61945604-E6B06D6B-5E85-4E3C-B544-C5A71EBD6DC6Q61945605-5D5FAB62-296E-4C9F-BB24-BDCC15387068Q61945606-F3392868-B362-4366-A155-28DE9D27AAF1Q61945607-45A5E71E-DAA8-4CBB-956E-4E48F4A8AE56Q61945608-F3B5FFDB-9657-4F20-A0F7-B774C7BF42DFQ61945609-09C915E7-A1C2-4CB8-8276-7E0B7E67154CQ61945610-BBDCEBFE-14C9-47D4-BB3A-4D325A697E5FQ61945611-77A13766-72CA-4F05-9F5B-5AC262C90CAAQ61945619-FC5B3912-53A1-423C-A4C7-129110E1A223
P50
description
researcher ORCID ID = 0000-0002-6344-4798
@en
name
Andrzej Torbe
@pl
Andrzej Torbé
@ast
Andrzej Torbé
@en
Andrzej Torbé
@es
Andrzej Torbé
@nl
type
label
Andrzej Torbe
@pl
Andrzej Torbé
@ast
Andrzej Torbé
@en
Andrzej Torbé
@es
Andrzej Torbé
@nl
prefLabel
Andrzej Torbe
@pl
Andrzej Torbé
@ast
Andrzej Torbé
@en
Andrzej Torbé
@es
Andrzej Torbé
@nl
P214
P1153
6602870008
P21
P214
P31
P496
0000-0002-6344-4798
P735
P7859
viaf-313521239